Previous 10 | Next 10 |
Adverum Biotechnologies, Inc. (ADVM) Q2 2019 Earnings Conference Call August 08, 2019 04:30 PM ET Company Participants Myesha Lacy - Vice President of Investor Relations & Corporate Communications Leone Patterson - Chief Executive Officer Aaron Osborne - Chief Medical Officer...
Adverum Biotechnologies (NASDAQ: ADVM ): Q2 GAAP EPS of -$0.23 beats by $0.04 . More news on: Adverum Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
-- Phase 1 OPTIC trial: 24-week data from first cohort to be presented at Retina Society in September; 52-week data to be presented in 1H20 -- -- Dosing of second cohort completed; 24-week data to be presented in 1H20 -- -- IND submission for ADVM-022 in diabetic retinopathy plann...
-- Director and Co-founder Mitchell Finer, Ph.D. to Retire for New Industry Role -- -- President, CSO Mehdi Gasmi, Ph.D. to Transition to Board of Directors -- -- Adverum Continues to Build Senior Team with Deep Functional Expertise with Three New Vice Presidents -- MENLO PARK,...
Shares of Adverum Biotechnologies ( ADVM ) have staged an impressive comeback thus far in 2019, rising by over 350% since the beginning of the year. Prior, the stock had been rangebound for quite some time following the company's coming into existence in its present form via 2016 merger of A...
MENLO PARK, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular diseases, today announced that it will host a conference call and audio webcast on Thursday, August 8, 2019 at 1:...
Biotech Pulse The first half of 2019 had a little bit of everything for biotechs. After a punishing close to last year, with the Nasdaq Biotechnology Index ( IBB ) down 10% for 2018, biotechs rebounded during the first quarter along with the broader market. However, the second quarter provid...
Gainers: Tarena International (NASDAQ: TEDU ) +38% . Outlook Therapeutics (NASDAQ: OTLK ) +30% . Exela Technologies (NASDAQ: XELA ) +23% . Neptune Wellness Solutions (NASDAQ: NEPT ) +15% . SilverCrest Metals (NYSEMKT: SILV ) +13% . NewLink Genetics Corporation (NASDAQ: NLNK ) +...
MENLO PARK, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointments of Carol Hoang, Pharm.D., MBA, to the newly-created position ...
MENLO PARK, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced presentations at the following upcoming conferences: Event: American Socie...
News, Short Squeeze, Breakout and More Instantly...
Adverum Biotechnologies Inc. Company Name:
ADVM Stock Symbol:
NASDAQ Market:
2024-04-27 03:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
REDWOOD CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the us...
REDWOOD CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that the company will present the 26-week landmark int...